| Target Price | $107.10 |
| Price | $98.35 |
| Potential |
8.90%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Hinge Health 2027 .
The average Hinge Health target price is $107.10.
This is
8.90%
register free of charge
$147.00
49.47%
register free of charge
$85.85
12.71%
register free of charge
|
|
| A rating was issued by 22 analysts: 20 Analysts recommend Hinge Health to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Hinge Health stock has an average upside potential 2027 of
8.90%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 587.86 | 876.34 |
| 50.58% | 49.07% | |
| EBITDA Margin | -92.07% | 29.60% |
| 1,845.02% | 132.15% | |
| Net Margin | -72.14% | 22.42% |
| 2,260.77% | 131.08% |
19 Analysts have issued a sales forecast Hinge Health 2026 . The average Hinge Health sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Hinge Health EBITDA forecast 2026. The average Hinge Health EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
19 Hinge Health Analysts have issued a net profit forecast 2026. The average Hinge Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -7.77 | 2.45 |
| 5,080.00% | 131.53% | |
| P/E | 39.87 | |
| EV/Sales | 8.55 |
19 Analysts have issued a Hinge Health forecast for earnings per share. The average Hinge Health EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham |
Locked
➜
Locked
|
Locked | Sep 30 2026 |
| Baird |
Locked
➜
Locked
|
Locked | Sep 22 2026 |
| Stifel |
Locked
➜
Locked
|
Locked | Sep 08 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham:
Locked
➜
Locked
|
Sep 30 2026 |
|
Locked
Baird:
Locked
➜
Locked
|
Sep 22 2026 |
|
Locked
Stifel:
Locked
➜
Locked
|
Sep 08 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 05 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


